355 related articles for article (PubMed ID: 9809902)
1. Placebo-controlled evaluations of propafenone for atrial tachyarrhythmias.
Rae AP
Am J Cardiol; 1998 Oct; 82(8A):59N-65N. PubMed ID: 9809902
[TBL] [Abstract][Full Text] [Related]
2. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
Chimienti M; Cullen MT; Casadei G
Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
[TBL] [Abstract][Full Text] [Related]
3. Safety and tolerability of long-term propafenone therapy for supraventricular tachyarrhythmias. The Propafenone Multicenter Study Group.
Podrid PJ; Anderson JL
Am J Cardiol; 1996 Aug; 78(4):430-4. PubMed ID: 8752188
[TBL] [Abstract][Full Text] [Related]
4. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
Circulation; 1995 Nov; 92(9):2550-7. PubMed ID: 7586356
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
Luedtke SA; Kuhn RJ; McCaffrey FM
Ann Pharmacother; 1997 Nov; 31(11):1347-59. PubMed ID: 9391691
[TBL] [Abstract][Full Text] [Related]
6. [Use of propafenone in emergency therapy].
Liguori A; Pellegrino G; Di Ieso N; Piatto A; Ruggiero P; Scarnera P; Guardascione A
Clin Ter; 1989 Dec; 131(5):307-14. PubMed ID: 2532584
[TBL] [Abstract][Full Text] [Related]
7. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
Hopson JR; Buxton AE; Rinkenberger RL; Nademanee K; Heilman JM; Kienzle MG
Am J Cardiol; 1996 Jan; 77(3):72A-82A. PubMed ID: 8607395
[TBL] [Abstract][Full Text] [Related]
8. Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy.
Pritchett EL; McCarthy EA; Wilkinson WE
Ann Intern Med; 1991 Apr; 114(7):539-44. PubMed ID: 2001087
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group.
Aliot E; Denjoy I
Am J Cardiol; 1996 Jan; 77(3):66A-71A. PubMed ID: 8607394
[TBL] [Abstract][Full Text] [Related]
10. Guidelines for the use of propafenone in treating supraventricular arrhythmias.
Kishore AG; Camm AJ
Drugs; 1995 Aug; 50(2):250-62. PubMed ID: 8521758
[TBL] [Abstract][Full Text] [Related]
11. Medical cardioversion of atrial fibrillation and flutter with class IC antiarrhythmic drugs in young patients with and without congenital heart disease.
Przybylski R; Eberly LM; Alexander ME; Bezzerides VJ; DeWitt ES; Dionne A; Mah DY; Triedman JK; Walsh EP; O'Leary ET
J Cardiovasc Electrophysiol; 2023 Dec; 34(12):2545-2551. PubMed ID: 37846208
[TBL] [Abstract][Full Text] [Related]
12. Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy.
Manz M; Lüderitz B
Eur Heart J; 1993 Sep; 14 Suppl E():91-8. PubMed ID: 8223763
[TBL] [Abstract][Full Text] [Related]
13. Propafenone for the treatment of supraventricular tachycardia and atrial fibrillation: a meta-analysis.
Reimold SC; Maisel WH; Antman EM
Am J Cardiol; 1998 Oct; 82(8A):66N-71N. PubMed ID: 9809903
[TBL] [Abstract][Full Text] [Related]
14. [Proarrhythmic effect of propafenone in patients with atrial fibrillation and atrial flutter].
Jastrzebski M
Kardiol Pol; 2008 Nov; 66(11):1221-4; discussion 1225. PubMed ID: 19105102
[TBL] [Abstract][Full Text] [Related]
15. [The efficacy of propafenon in the case of supraventricular atrioventricular tachycardia].
Chachua T; Abuladze G; Nebieridze M
Georgian Med News; 2010 Jun; (183):18-21. PubMed ID: 20622270
[TBL] [Abstract][Full Text] [Related]
16. Intravenous propafenone in paroxysmal atrial fibrillation: a randomized, placebo-controlled, double-blind, multicenter clinical trial. Paroxysmal Atrial Fibrillation Italian Trial (PAFIT)-2 Investigators.
Fresco C; Proclemer A; Pavan A; Buia G; Vicentini A; Pavan D; Morgera T
Clin Cardiol; 1996 May; 19(5):409-12. PubMed ID: 8723601
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of propafenone in supraventricular arrhythmias].
Kauffmann R; Goich J; Parra C; Ayala A; Manzur F
Rev Med Chil; 1989 Apr; 117(4):401-5. PubMed ID: 2519393
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacology of modern anti-arrhythmia drugs in therapy of supraventricular tachycardia].
Honerjäger P; Schmidt G
Z Gesamte Inn Med; 1993 Sep; 48(9):425-9. PubMed ID: 8212747
[TBL] [Abstract][Full Text] [Related]
19. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study.
Bianconi L; Mennuni M; Lukic V; Castro A; Chieffi M; Santini M
J Am Coll Cardiol; 1996 Sep; 28(3):700-6. PubMed ID: 8772759
[TBL] [Abstract][Full Text] [Related]
20. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].
Zhang HC; Guo JH; Fang Q; Zheng YA; Sun YM; Zhu WQ; Wan Z; Guo JX; Ge JB; Han SM
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):798-801. PubMed ID: 15949393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
